Predict your next investment

Venture Capital
cutlasscapital.com

See what CB Insights has to offer

Investments

22

Portfolio Exits

7

Funds

1

About Cutlass Capital

Cutlass Capital is a private venture capital partnership investing exclusively in the health care industry. Cutlass Capital was established in August 2001 by Jon Osgood and David Hetz with committed capital of over $57 million. We evaluate equity investment opportunities in companies at all stages of development and in all sectors of the health care industry, with a particular focus on the medical device and specialty health care services sectors. Our offices are in Boston and San Francisco.

Cutlass Capital Headquarter Location

229 Marlborough Street

Boston, Massachusetts, 02116,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Cutlass Capital Investments

22 Investments

Cutlass Capital has made 22 investments. Their latest investment was in TherOx as part of their Unattributed VC - IV on May 5, 2018.

CBI Logo

Cutlass Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/10/2018

Unattributed VC - IV

TherOx

$15M

Yes

1

3/23/2010

Unattributed VC - II

Hemosphere

$9.35M

No

2/11/2009

Series C - II

GI Dynamics

$45M

No

8/22/2008

Series E

Subscribe to see more

$99M

Subscribe to see more

0

7/9/2008

Series C

Subscribe to see more

$99M

Subscribe to see more

0

Date

5/10/2018

3/23/2010

2/11/2009

8/22/2008

7/9/2008

Round

Unattributed VC - IV

Unattributed VC - II

Series C - II

Series E

Series C

Company

TherOx

Hemosphere

GI Dynamics

Subscribe to see more

Subscribe to see more

Amount

$15M

$9.35M

$45M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

0

0

Cutlass Capital Portfolio Exits

7 Portfolio Exits

Cutlass Capital has 7 portfolio exits. Their latest portfolio exit was TherOx on June 18, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/18/2019

Acquired

$99M

3

5/15/2012

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

8/30/2011

IPO

Subscribe to see more

$99M

Subscribe to see more

10

12/21/2010

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

9/11/2009

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/18/2019

5/15/2012

8/30/2011

12/21/2010

9/11/2009

Exit

Acquired

Acquired

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

0

10

Cutlass Capital Fund History

1 Fund History

Cutlass Capital has 1 fund, including Cutlass Capital, L.P..

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/31/2002

Cutlass Capital, L.P.

Multi-Stage Venture Capital

Closed

$57M

1

Closing Date

7/31/2002

Fund

Cutlass Capital, L.P.

Fund Type

Multi-Stage Venture Capital

Status

Closed

Amount

$57M

Sources

1

Cutlass Capital Team

2 Team Members

Cutlass Capital has 2 team members, including current Founder, E. David Hetz.

Name

Work History

Title

Status

E. David Hetz

Founder

Current

Jonathan W. Osgood

Founder

Current

Name

E. David Hetz

Jonathan W. Osgood

Work History

Title

Founder

Founder

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.